61
Views
0
CrossRef citations to date
0
Altmetric
Review

Genetic Causes of Stroke and Vascular Dementia

, &
Pages 497-504 | Published online: 24 May 2006

Bibliography

  • Hassan A , MarkusHS: Genetics and ischemic stroke.Brain123, 1784–1812(2000).
  • Humphries SE , MorganL: Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches.Lancet Neurol.3, 227–236(2004).
  • O‘Brien JT , ErkinjunttiT, ReisbergBet al.: Vascular cognitive impairment.Lancet Neurol.2, 89–98(2003).
  • Kalaria R : Similarities between Alzheimer‘s disease and vascular dementia.J. Neurol. Sci.203–204, 29–34(2002).
  • Ritchie K , LovestoneS: The dementias.Lancet360, 1759–1766(2002).
  • Langa KM , FosterNL, LarsonEB: Mixed dementia. Emerging concepts and therapeutic implications.JAMA292, 2901–2908(2004).
  • Lin HF , LaiCL, TaiCT, LinRT, LiuCK: Apolipoprotein E polymorphism in ischemic cerebrovascular diseases and vascular dementia in Taiwan.Neuroepidemiology23, 129–134(2004).
  • Cerrato P , BaimaC, GrassoMet al.: Apolipoprotein E polymorphism and stroke subtypes in an Italian cohort.Cerebrovasc. Dis.20, 264–269(2005).
  • Duzenli S , PirimI, GepdiremenA, Deniz O: Apolipoprotein E polymorphism and stroke in a population from eastern Turkey. J. Neurogenet.18, 365–375(2004).
  • Jin ZQ , FanYS, DingJet al.: Association of apolipoprotein E 4 polymorphism with cerebral infarction in Chinese Han population.Acta Pharmacol. Sin.25, 352–356(2004).
  • Slooter AJ , CrutsM, HofmanAet al.: The impact of APOE on myocardial infarction, stroke, and dementia: the Rotterdam Study.Neurology62, 1196–1198(2004).
  • Van Dijk EJ , PrinsND, VermeerSEet al.: Plasma amyloid beta, apolipoprotein E, lacunar infarcts, and white matter lesions.Ann. Neurol.55, 570–575(2004).
  • Casas JP , HingoraniAD, BautistaLEet al.: Meta-analysis of genetic studies in ischemic stroke.Arch. Neurol.61, 1652–1662(2004).
  • Lalouschek W , SchillingerM, HsiehKet al.: Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years. Stroke36, 1405–1409(2005).
  • Sharma P : Meta-analysis of the ACE gene in ischemic stroke.J. Neurol. Neurosurg. Psychiatr.64, 227–230(1998).
  • Alberts MJ , Tournier-LasserveE: Update on the genetics of stroke and cerebrovascular disease 2004.Stroke36, 179–181(2005).
  • Gulcher JR , GretarsdottirS, HelgadottirAet al.: Genes contributing to risk for common forms of stroke. Trends Mol. Med.11, 217–224(2005).
  • Salheen D , BukhariS, HaiderSRet al.: Association of phosphodiesterase 4D gene with ischemic stroke in a Pakistani population.Stroke36, 2275–2277(2005).
  • Bevan S , PorteousL, SitzerMet al.: Phosphodiesterase 4D gene, ischemic stroke, and asymptomatic atherosclerosis.Stroke36, 949–953(2005).
  • Helgadottir A , ManolescuA, ThorleifssonGet al.: The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke.Nat. Genet.36, 233–239(2004).
  • Sebastiani P , RamoniMF, NolanV, BaldwinCT, SteinbergMH: Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia.Nat. Genet.37, 340–341(2005).
  • Rolfs A , BottcherT, ZschiescheMet al.: Prevalence of Fabry disease in patients with cryptogenic stroke. A prospective study.Lancet366, 1754–1756(2005).
  • Lesnik Oberstein SAJ , Haan J: CADASIL. Panminerva Med.46, 265–276(2004).
  • Opherk C , PetersN, HerzogJ, LuedtkeR, DichgansM: Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients.Brain127, 2533–2539(2004).
  • Lesnik Oberstein SAJ , van den Boom R, Middelkoop HA et al.: Incipient CADASIL. Arch. Neurol.60, 707–712(2003).
  • Dichgans M , MayerM, UttnerIet al.: The phenotypic spectrum of CADASIL: clinical findings in 102 cases.Ann. Neurol.44, 731–739(1998).
  • Lesnik Oberstein SAJ , Jukema JW, Van Duinen SG et al.: Myocardial infarction in CADASIL. Medicine (Baltimore)82, 251–256(2003).
  • van den Boom R , Lesnik Oberstein SAJ, Ferrari MD, Haan J, van Buchem MA: CADASIL lesions on MRI in different age groups – third through sixth decades. Radiology229, 683–590(2003).
  • van den Boom R , Lesnik Oberstein SAJ, Bornebroek M, Ferrari MD, Haan J, van Buchem MA: Subcortical lacunar lesions, a novel MRI finding in CADASIL. Radiology224, 791–796(2002).
  • Lesnik Oberstein SAJ , van den Boom R, van Buchem MA et al.: Cerebral microbleeds in CADASIL. Neurology57, 1066–1070(2001).
  • Peters N , OpherkC, BergmannT, CastroM, HerzogJ, DichgansM: Spectrum of mutations in biopsy-proven CADASIL.Arch. Neurol.62, 1091–1094(2005).
  • Polychronopoulos P , GioldasisG, EllulJet al.: Family history of stroke in stroke types and subtypes. J. Neurol. Sci.195, 117–122(2002).
  • Alberts MJ , McCarronMO, HoffmannKL, GraffagninoC: Familial clustering of intracerebral hemorrhage: a prospective study in North Carolina.Neuroepidemiology21, 18–21(2002).
  • Kalaria RN : Advances in molecular genetics and pathology of cerebrovascular disorders.Trends Neurosci.24, 392–400(2001).
  • Alberts MJ , DavisJP, GraffagninoCet al.: Endoglin gene polymorphism as a risk factor for sporadic intracerebral hemorrhage.Ann. Neurol.41, 683–686(1997).
  • Yoshida H , ImaizumiT, FujimotoKet al.: A mutation in plasma-activating factor acetylhydrolase (Val279Phe) is a genetic risk factor for cerebral hemorrhage but not for hypertension.Thromb. Haemost.80, 372–375(1998).
  • Obach V , RevillaM, VilaN, CerveraA, ChamorroA: α1-antichymotrypsin polymorphism. A risk factor for hemorrhagic stroke in normotensive subjects.Stroke32, 2588–2591(2001).
  • Catto AJ , KohlerHP, BannanS, SticklandM, CarterA, GrantPJ: Factor XIII Val 34 Leu. A novel association with primary intracerebral hemorrhage.Stroke29, 813–816(1998).
  • Gemmati D , SerinoML, OngaroAet al.: A common mutation in the gene for coagulation factor XIII-A (val34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic disease.Am. J. Hematol.67, 183–188(2001).
  • Reiner AP , SchwartzSM, FrankMBet al.: Polymorphisms of coagulation factor XIII subunit A and risk of nonfatal hemorrhagic stroke in young white women.Stroke32, 2580–2586(2001).
  • Slowik A , TurajW, DziedzikTet al.: DD genotype of ACE gene is a risk factor for intracerebral hemorrhage.Neurology63, 359–361(2004).
  • Xia J , YangQD, YangQMet al.: Apolipoprotein H gene polymorphisms and risk of primary cerebral hemorrhage in a Chinese population.Cerebrovasc. Dis.17, 197–203(2004).
  • Nicoll JA , McCarronMO: APOE gene polymorphism as a risk factor for cerebral amyloid angiopathy-related hemorrhage.Amyloid8(Suppl. I), 51–55(2001).
  • McCarron MO , NicollJAR: Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage.Ann. NY Acad. Sci.903, 176–179(2000).
  • Woo D , SauerbeckLR, KisselaBMet al.: Genetic and environmental risk factors for intracerebral hemorrhage. Preliminary results of a population-based study.Stroke33, 1190–1196(2002).
  • Gebel JM , BroderickJP: Intracerebral hemorrhage.Neurol. Clin.19, 419–438(2000).
  • Lammie GA : Hypertensive cerebral small vessel disease and stroke.Brain Pathol.12, 358–370(2002).
  • Doris PA : Hypertension genetics, single nucleotide polymorphisms, and the common disease: common variant hypothesis.Hypertension39, 323–331(2002).
  • Labovitz DL , SaccoRL: Intracerebral hemorrhage: update.Curr. Opin. Neurol.14, 103–108(2001).
  • Ortel TL : Genetics of coagulation disorders. In:Genetics of Cerebrovascular Disease. Alberts MJ (Ed.). Futura Publishing Company, NY, USA, 129–156(1999).
  • Haan J : Hereditary cerebral amyloid angiopathies. In:Stroke. Predisposing Conditions. Leys D (Ed.). Remedica Publishing, London, UK, 79–88(2002).
  • Haan J , BakkerB, Jennekens-SchinkelA, RoosRA: Progressive dementia, without cerebral hemorrhage in a patient with hereditary cerebral amyloid angiopathy.Clin. Neurol. Neurosurg.94, 317–318(1992).
  • Revesz T , GhisoJ, LashleyTet al.: Cerebral amyloid angiopathies: a pathologic, biochemical and genetic review.J. Neuropathol. Exp. Neurol.62, 885–898(2003).
  • Greenberg SM , VonsattelJP, StakesJW, GruberM, FinklesteinSP: The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage.Neurology43, 2073–2079(1993).
  • Ferro JM : Hyperacute cognitive stroke syndromes.J. Neurol.248, 841–849(2001).
  • Gorelick PB : Risk factors for vascular dementia and Alzheimer disease.Stroke35(Suppl. I), 2620–2622(2004).
  • Koelsch H , LinnebankM, LuetjohannDet al.: Polymorphisms in glutathione S-transferase omega-1 and AD, vascular dementia, and stroke. Neurology63, 2255–2260(2004).
  • Koelsch H , JessenF, FreymannNet al.: ACE I/D polymorphism is a risk factor of Alzheimer‘s disease but not of vascular dementia.Neurosci. Lett.377, 37–39(2005).
  • Pollak RD , PollakA, IdelsonM, Bejarano-AchacheI, DoronD, Blumenfeld A: The C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene and vascular dementia. J. Am. Geriatr. Soc.48, 664–668(2000).
  • Chapman J , WangN, TrevesTA, KorczynAD, BornsteinNM: ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer‘s dementia.Stroke29, 1401–1404(1998).
  • Kuo YM , LiaoPC, LinCet al.: Lack of association bewteen interleukin-1alpha polymorphism and Alzheimer disease or vascular dementia.Alzheimer Dis. Assoc. Disord.17, 94–97(2003).
  • Terreni L , FogliarinoS, QuadriPet al.: Tumor necrosis factor alpha polymorphism C-850T is not associated with Alzheimer‘s disease and vascular dementia in an Italian population.Neurosci. Lett.344, 135–137(2003).
  • Matsushita S , AraiH, MuramatsuTet al.: Presenilin-1 polymorphism in Alzheimer‘s disease and vascular dementia.Exp. Neurol.146, 567–569(1997).
  • Merino JG , HachinskiV: Stroke-related dementia.Curr. Atheroscler. Rep.4, 285–290(2002).
  • Arpa A , del Ser T, Goda G, Barba R, Bornstein B: Apolipoprotein E, angiotensin-converting enzyme and alpha-1-antichymotrypsin genotypes are not associated with post-stroke dementia. J. Neurol. Sci.210, 77–82(2003).
  • Slooter AJ , TangMX, van Duijn CM et al.: Apolipoprotein E ε4 and the risk of dementia with stroke. A population based investigation. JAMA277, 818–821(1997).
  • Klimowicz A , SlowikA, DziedzicT, PolczykR, SzczudlikA: Post-stroke dementia is associated with α1-antichymotrypsin polymorphism.J. Neurol. Sci.234, 31–36(2005).
  • Prengler M , PavlakisSG, ProhovnikI, AdamsRJ: Sickle cell disease: the neurological complications.Ann. Neurol.51, 543–552(2002).
  • Mendez MF , StanleyTM, MedelNM, LiZ, TedescoDT: The vascular dementia of Fabry‘s disease.Dement. Geriatr. Cogn. Disord.8, 252–257(1997).
  • Bornebroek M , HaanJ, RoosRA: HCHWA-D: a review of the variety in phenotypic expression.Amyloid6, 215–224(1999).
  • Maat-Schieman ML , van Duinen SG, Bornebroek M, Haan J, Roos RA: Hereditary cerebral hemorrhage with amyloidosis – Dutch type (HCHWA-D): II- A review of histopathological aspects. Brain Pathol.6, 115–120(1996).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.